A Pilot Study of the Effect of Testosterone on Cerebral Glucose Metabolism in Hypogonadal Males With Mild Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2010
At a glance
- Drugs Testosterone (Primary)
- Indications Alzheimer's disease; Hypogonadism
- Focus Pharmacodynamics
- 18 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2010 Actual patient number (10) added as reported by ClinicalTrials.gov.
- 18 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.